nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—CA5B—cervicothoracic ganglion—systemic scleroderma	0.162	0.64	CbGeAlD
Brinzolamide—CA7—digestive system—systemic scleroderma	0.00818	0.0323	CbGeAlD
Brinzolamide—CA12—connective tissue—systemic scleroderma	0.00736	0.0291	CbGeAlD
Brinzolamide—CA9—digestive system—systemic scleroderma	0.00718	0.0284	CbGeAlD
Brinzolamide—CA9—tendon—systemic scleroderma	0.00684	0.027	CbGeAlD
Brinzolamide—CA14—tendon—systemic scleroderma	0.00648	0.0256	CbGeAlD
Brinzolamide—CA12—digestive system—systemic scleroderma	0.00531	0.021	CbGeAlD
Brinzolamide—CA5B—tendon—systemic scleroderma	0.00454	0.0179	CbGeAlD
Brinzolamide—CA12—lung—systemic scleroderma	0.00444	0.0175	CbGeAlD
Brinzolamide—CA1—digestive system—systemic scleroderma	0.00421	0.0166	CbGeAlD
Brinzolamide—CA5B—lung—systemic scleroderma	0.00398	0.0157	CbGeAlD
Brinzolamide—CA2—connective tissue—systemic scleroderma	0.00378	0.0149	CbGeAlD
Brinzolamide—CA1—lung—systemic scleroderma	0.00352	0.0139	CbGeAlD
Brinzolamide—CA2—smooth muscle tissue—systemic scleroderma	0.00345	0.0136	CbGeAlD
Brinzolamide—CA2—skin of body—systemic scleroderma	0.00341	0.0135	CbGeAlD
Brinzolamide—CA4—digestive system—systemic scleroderma	0.00329	0.013	CbGeAlD
Brinzolamide—CA4—tendon—systemic scleroderma	0.00313	0.0124	CbGeAlD
Brinzolamide—CA4—lung—systemic scleroderma	0.00275	0.0109	CbGeAlD
Brinzolamide—CA2—digestive system—systemic scleroderma	0.00273	0.0108	CbGeAlD
Brinzolamide—CA2—tendon—systemic scleroderma	0.0026	0.0103	CbGeAlD
Brinzolamide—CA2—lung—systemic scleroderma	0.00228	0.009	CbGeAlD
Brinzolamide—CYP3A4—digestive system—systemic scleroderma	0.00176	0.00695	CbGeAlD
Brinzolamide—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000897	0.0012	CcSEcCtD
Brinzolamide—Tension—Mycophenolate mofetil—systemic scleroderma	0.000894	0.0012	CcSEcCtD
Brinzolamide—Insomnia—Leflunomide—systemic scleroderma	0.000893	0.0012	CcSEcCtD
Brinzolamide—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000892	0.00119	CcSEcCtD
Brinzolamide—Paraesthesia—Leflunomide—systemic scleroderma	0.000886	0.00119	CcSEcCtD
Brinzolamide—Chest pain—Lisinopril—systemic scleroderma	0.000885	0.00118	CcSEcCtD
Brinzolamide—Arthralgia—Lisinopril—systemic scleroderma	0.000885	0.00118	CcSEcCtD
Brinzolamide—Myalgia—Lisinopril—systemic scleroderma	0.000885	0.00118	CcSEcCtD
Brinzolamide—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000885	0.00118	CcSEcCtD
Brinzolamide—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000881	0.00118	CcSEcCtD
Brinzolamide—Dyspnoea—Leflunomide—systemic scleroderma	0.00088	0.00118	CcSEcCtD
Brinzolamide—Hypotension—Mycophenolic acid—systemic scleroderma	0.00088	0.00118	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000879	0.00118	CcSEcCtD
Brinzolamide—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000876	0.00117	CcSEcCtD
Brinzolamide—Discomfort—Lisinopril—systemic scleroderma	0.000874	0.00117	CcSEcCtD
Brinzolamide—Dyspepsia—Leflunomide—systemic scleroderma	0.000869	0.00116	CcSEcCtD
Brinzolamide—Vomiting—Mometasone—systemic scleroderma	0.000867	0.00116	CcSEcCtD
Brinzolamide—Dry mouth—Lisinopril—systemic scleroderma	0.000865	0.00116	CcSEcCtD
Brinzolamide—Feeling abnormal—Azathioprine—systemic scleroderma	0.000861	0.00115	CcSEcCtD
Brinzolamide—Rash—Mometasone—systemic scleroderma	0.00086	0.00115	CcSEcCtD
Brinzolamide—Asthenia—Captopril—systemic scleroderma	0.000859	0.00115	CcSEcCtD
Brinzolamide—Dermatitis—Mometasone—systemic scleroderma	0.000859	0.00115	CcSEcCtD
Brinzolamide—Decreased appetite—Leflunomide—systemic scleroderma	0.000858	0.00115	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000858	0.00115	CcSEcCtD
Brinzolamide—Headache—Mometasone—systemic scleroderma	0.000854	0.00114	CcSEcCtD
Brinzolamide—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000853	0.00114	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000852	0.00114	CcSEcCtD
Brinzolamide—Insomnia—Mycophenolic acid—systemic scleroderma	0.000852	0.00114	CcSEcCtD
Brinzolamide—Fatigue—Leflunomide—systemic scleroderma	0.000851	0.00114	CcSEcCtD
Brinzolamide—Pruritus—Captopril—systemic scleroderma	0.000847	0.00113	CcSEcCtD
Brinzolamide—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000846	0.00113	CcSEcCtD
Brinzolamide—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000845	0.00113	CcSEcCtD
Brinzolamide—Pain—Leflunomide—systemic scleroderma	0.000844	0.00113	CcSEcCtD
Brinzolamide—Infection—Lisinopril—systemic scleroderma	0.000843	0.00113	CcSEcCtD
Brinzolamide—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00084	0.00112	CcSEcCtD
Brinzolamide—Somnolence—Mycophenolic acid—systemic scleroderma	0.000837	0.00112	CcSEcCtD
Brinzolamide—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000837	0.00112	CcSEcCtD
Brinzolamide—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000829	0.00111	CcSEcCtD
Brinzolamide—Tachycardia—Lisinopril—systemic scleroderma	0.000828	0.00111	CcSEcCtD
Brinzolamide—Skin disorder—Lisinopril—systemic scleroderma	0.000824	0.0011	CcSEcCtD
Brinzolamide—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000821	0.0011	CcSEcCtD
Brinzolamide—Diarrhoea—Captopril—systemic scleroderma	0.00082	0.0011	CcSEcCtD
Brinzolamide—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000819	0.0011	CcSEcCtD
Brinzolamide—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000818	0.0011	CcSEcCtD
Brinzolamide—Irritability—Methotrexate—systemic scleroderma	0.000818	0.00109	CcSEcCtD
Brinzolamide—Erectile dysfunction—Prednisone—systemic scleroderma	0.000816	0.00109	CcSEcCtD
Brinzolamide—Feeling abnormal—Leflunomide—systemic scleroderma	0.000814	0.00109	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000813	0.00109	CcSEcCtD
Brinzolamide—Fatigue—Mycophenolic acid—systemic scleroderma	0.000812	0.00109	CcSEcCtD
Brinzolamide—Nausea—Mometasone—systemic scleroderma	0.00081	0.00108	CcSEcCtD
Brinzolamide—Pain—Mycophenolic acid—systemic scleroderma	0.000805	0.00108	CcSEcCtD
Brinzolamide—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000805	0.00108	CcSEcCtD
Brinzolamide—Cough—Mycophenolate mofetil—systemic scleroderma	0.000795	0.00106	CcSEcCtD
Brinzolamide—Hypotension—Lisinopril—systemic scleroderma	0.000793	0.00106	CcSEcCtD
Brinzolamide—Dizziness—Captopril—systemic scleroderma	0.000792	0.00106	CcSEcCtD
Brinzolamide—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000791	0.00106	CcSEcCtD
Brinzolamide—Depression—Prednisone—systemic scleroderma	0.000788	0.00105	CcSEcCtD
Brinzolamide—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000786	0.00105	CcSEcCtD
Brinzolamide—Urticaria—Leflunomide—systemic scleroderma	0.000784	0.00105	CcSEcCtD
Brinzolamide—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000776	0.00104	CcSEcCtD
Brinzolamide—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000775	0.00104	CcSEcCtD
Brinzolamide—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000775	0.00104	CcSEcCtD
Brinzolamide—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000775	0.00104	CcSEcCtD
Brinzolamide—Breast disorder—Methotrexate—systemic scleroderma	0.000774	0.00104	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000773	0.00103	CcSEcCtD
Brinzolamide—Hypersensitivity—Azathioprine—systemic scleroderma	0.00077	0.00103	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00077	0.00103	CcSEcCtD
Brinzolamide—Insomnia—Lisinopril—systemic scleroderma	0.000767	0.00103	CcSEcCtD
Brinzolamide—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000766	0.00103	CcSEcCtD
Brinzolamide—Paraesthesia—Lisinopril—systemic scleroderma	0.000762	0.00102	CcSEcCtD
Brinzolamide—Vomiting—Captopril—systemic scleroderma	0.000762	0.00102	CcSEcCtD
Brinzolamide—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000758	0.00102	CcSEcCtD
Brinzolamide—Dyspnoea—Lisinopril—systemic scleroderma	0.000756	0.00101	CcSEcCtD
Brinzolamide—Rash—Captopril—systemic scleroderma	0.000755	0.00101	CcSEcCtD
Brinzolamide—Dermatitis—Captopril—systemic scleroderma	0.000755	0.00101	CcSEcCtD
Brinzolamide—Somnolence—Lisinopril—systemic scleroderma	0.000754	0.00101	CcSEcCtD
Brinzolamide—Headache—Captopril—systemic scleroderma	0.00075	0.001	CcSEcCtD
Brinzolamide—Dyspepsia—Lisinopril—systemic scleroderma	0.000747	0.001	CcSEcCtD
Brinzolamide—Asthma—Methotrexate—systemic scleroderma	0.00074	0.000991	CcSEcCtD
Brinzolamide—Infection—Mycophenolate mofetil—systemic scleroderma	0.000738	0.000989	CcSEcCtD
Brinzolamide—Decreased appetite—Lisinopril—systemic scleroderma	0.000737	0.000987	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000732	0.000981	CcSEcCtD
Brinzolamide—Fatigue—Lisinopril—systemic scleroderma	0.000731	0.000979	CcSEcCtD
Brinzolamide—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000729	0.000976	CcSEcCtD
Brinzolamide—Hypersensitivity—Leflunomide—systemic scleroderma	0.000727	0.000974	CcSEcCtD
Brinzolamide—Pain—Lisinopril—systemic scleroderma	0.000725	0.000971	CcSEcCtD
Brinzolamide—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000725	0.000971	CcSEcCtD
Brinzolamide—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000722	0.000967	CcSEcCtD
Brinzolamide—Bradycardia—Prednisone—systemic scleroderma	0.000722	0.000967	CcSEcCtD
Brinzolamide—Diarrhoea—Azathioprine—systemic scleroderma	0.000715	0.000958	CcSEcCtD
Brinzolamide—Nausea—Captopril—systemic scleroderma	0.000711	0.000953	CcSEcCtD
Brinzolamide—Abdominal discomfort—Methotrexate—systemic scleroderma	0.00071	0.00095	CcSEcCtD
Brinzolamide—Asthenia—Leflunomide—systemic scleroderma	0.000708	0.000948	CcSEcCtD
Brinzolamide—Feeling abnormal—Lisinopril—systemic scleroderma	0.000699	0.000936	CcSEcCtD
Brinzolamide—Pruritus—Leflunomide—systemic scleroderma	0.000698	0.000935	CcSEcCtD
Brinzolamide—Connective tissue disorder—Prednisone—systemic scleroderma	0.000697	0.000933	CcSEcCtD
Brinzolamide—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000695	0.00093	CcSEcCtD
Brinzolamide—Dizziness—Azathioprine—systemic scleroderma	0.000691	0.000926	CcSEcCtD
Brinzolamide—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000682	0.000913	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000677	0.000907	CcSEcCtD
Brinzolamide—Asthenia—Mycophenolic acid—systemic scleroderma	0.000676	0.000905	CcSEcCtD
Brinzolamide—Diarrhoea—Leflunomide—systemic scleroderma	0.000675	0.000904	CcSEcCtD
Brinzolamide—Urticaria—Lisinopril—systemic scleroderma	0.000674	0.000902	CcSEcCtD
Brinzolamide—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000672	0.0009	CcSEcCtD
Brinzolamide—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000667	0.000894	CcSEcCtD
Brinzolamide—Pruritus—Mycophenolic acid—systemic scleroderma	0.000666	0.000892	CcSEcCtD
Brinzolamide—Vomiting—Azathioprine—systemic scleroderma	0.000665	0.00089	CcSEcCtD
Brinzolamide—Eye disorder—Prednisone—systemic scleroderma	0.000663	0.000887	CcSEcCtD
Brinzolamide—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000663	0.000887	CcSEcCtD
Brinzolamide—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000661	0.000885	CcSEcCtD
Brinzolamide—Infestation—Methotrexate—systemic scleroderma	0.00066	0.000884	CcSEcCtD
Brinzolamide—Infestation NOS—Methotrexate—systemic scleroderma	0.00066	0.000884	CcSEcCtD
Brinzolamide—Rash—Azathioprine—systemic scleroderma	0.000659	0.000883	CcSEcCtD
Brinzolamide—Dermatitis—Azathioprine—systemic scleroderma	0.000659	0.000882	CcSEcCtD
Brinzolamide—Depression—Methotrexate—systemic scleroderma	0.000658	0.000881	CcSEcCtD
Brinzolamide—Headache—Azathioprine—systemic scleroderma	0.000655	0.000877	CcSEcCtD
Brinzolamide—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000654	0.000876	CcSEcCtD
Brinzolamide—Dizziness—Leflunomide—systemic scleroderma	0.000653	0.000874	CcSEcCtD
Brinzolamide—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000646	0.000865	CcSEcCtD
Brinzolamide—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000644	0.000863	CcSEcCtD
Brinzolamide—Angiopathy—Prednisone—systemic scleroderma	0.000643	0.000862	CcSEcCtD
Brinzolamide—Conjunctivitis—Methotrexate—systemic scleroderma	0.000642	0.000859	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000642	0.000859	CcSEcCtD
Brinzolamide—Immune system disorder—Prednisone—systemic scleroderma	0.000641	0.000858	CcSEcCtD
Brinzolamide—Pain—Mycophenolate mofetil—systemic scleroderma	0.000636	0.000851	CcSEcCtD
Brinzolamide—Arrhythmia—Prednisone—systemic scleroderma	0.000633	0.000848	CcSEcCtD
Brinzolamide—Vomiting—Leflunomide—systemic scleroderma	0.000628	0.00084	CcSEcCtD
Brinzolamide—Alopecia—Prednisone—systemic scleroderma	0.000627	0.000839	CcSEcCtD
Brinzolamide—Hypersensitivity—Lisinopril—systemic scleroderma	0.000625	0.000837	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000624	0.000836	CcSEcCtD
Brinzolamide—Dizziness—Mycophenolic acid—systemic scleroderma	0.000623	0.000834	CcSEcCtD
Brinzolamide—Epistaxis—Methotrexate—systemic scleroderma	0.000623	0.000834	CcSEcCtD
Brinzolamide—Rash—Leflunomide—systemic scleroderma	0.000622	0.000833	CcSEcCtD
Brinzolamide—Dermatitis—Leflunomide—systemic scleroderma	0.000622	0.000833	CcSEcCtD
Brinzolamide—Mental disorder—Prednisone—systemic scleroderma	0.000621	0.000832	CcSEcCtD
Brinzolamide—Nausea—Azathioprine—systemic scleroderma	0.000621	0.000831	CcSEcCtD
Brinzolamide—Headache—Leflunomide—systemic scleroderma	0.000618	0.000828	CcSEcCtD
Brinzolamide—Erythema—Prednisone—systemic scleroderma	0.000617	0.000827	CcSEcCtD
Brinzolamide—Malnutrition—Prednisone—systemic scleroderma	0.000617	0.000827	CcSEcCtD
Brinzolamide—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000612	0.00082	CcSEcCtD
Brinzolamide—Asthenia—Lisinopril—systemic scleroderma	0.000609	0.000815	CcSEcCtD
Brinzolamide—Pruritus—Lisinopril—systemic scleroderma	0.0006	0.000804	CcSEcCtD
Brinzolamide—Vomiting—Mycophenolic acid—systemic scleroderma	0.000599	0.000802	CcSEcCtD
Brinzolamide—Rash—Mycophenolic acid—systemic scleroderma	0.000594	0.000795	CcSEcCtD
Brinzolamide—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000593	0.000794	CcSEcCtD
Brinzolamide—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00059	0.000791	CcSEcCtD
Brinzolamide—Headache—Mycophenolic acid—systemic scleroderma	0.00059	0.00079	CcSEcCtD
Brinzolamide—Pharyngitis—Methotrexate—systemic scleroderma	0.000588	0.000788	CcSEcCtD
Brinzolamide—Nausea—Leflunomide—systemic scleroderma	0.000586	0.000785	CcSEcCtD
Brinzolamide—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000585	0.000784	CcSEcCtD
Brinzolamide—Vision blurred—Prednisone—systemic scleroderma	0.000582	0.000779	CcSEcCtD
Brinzolamide—Urethral disorder—Methotrexate—systemic scleroderma	0.000581	0.000778	CcSEcCtD
Brinzolamide—Diarrhoea—Lisinopril—systemic scleroderma	0.00058	0.000777	CcSEcCtD
Brinzolamide—Ill-defined disorder—Prednisone—systemic scleroderma	0.000573	0.000767	CcSEcCtD
Brinzolamide—Visual impairment—Methotrexate—systemic scleroderma	0.000571	0.000765	CcSEcCtD
Brinzolamide—Agitation—Prednisone—systemic scleroderma	0.000567	0.00076	CcSEcCtD
Brinzolamide—Dizziness—Lisinopril—systemic scleroderma	0.000561	0.000751	CcSEcCtD
Brinzolamide—Nausea—Mycophenolic acid—systemic scleroderma	0.000559	0.000749	CcSEcCtD
Brinzolamide—Malaise—Prednisone—systemic scleroderma	0.000557	0.000745	CcSEcCtD
Brinzolamide—Vertigo—Prednisone—systemic scleroderma	0.000555	0.000743	CcSEcCtD
Brinzolamide—Eye disorder—Methotrexate—systemic scleroderma	0.000554	0.000742	CcSEcCtD
Brinzolamide—Tinnitus—Methotrexate—systemic scleroderma	0.000553	0.00074	CcSEcCtD
Brinzolamide—Cardiac disorder—Methotrexate—systemic scleroderma	0.00055	0.000736	CcSEcCtD
Brinzolamide—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000548	0.000733	CcSEcCtD
Brinzolamide—Vomiting—Lisinopril—systemic scleroderma	0.000539	0.000722	CcSEcCtD
Brinzolamide—Angiopathy—Methotrexate—systemic scleroderma	0.000538	0.00072	CcSEcCtD
Brinzolamide—Immune system disorder—Methotrexate—systemic scleroderma	0.000535	0.000717	CcSEcCtD
Brinzolamide—Rash—Lisinopril—systemic scleroderma	0.000535	0.000716	CcSEcCtD
Brinzolamide—Dermatitis—Lisinopril—systemic scleroderma	0.000534	0.000716	CcSEcCtD
Brinzolamide—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000534	0.000715	CcSEcCtD
Brinzolamide—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000533	0.000714	CcSEcCtD
Brinzolamide—Hypertension—Prednisone—systemic scleroderma	0.000533	0.000714	CcSEcCtD
Brinzolamide—Headache—Lisinopril—systemic scleroderma	0.000531	0.000712	CcSEcCtD
Brinzolamide—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000526	0.000704	CcSEcCtD
Brinzolamide—Myalgia—Prednisone—systemic scleroderma	0.000526	0.000704	CcSEcCtD
Brinzolamide—Arthralgia—Prednisone—systemic scleroderma	0.000526	0.000704	CcSEcCtD
Brinzolamide—Alopecia—Methotrexate—systemic scleroderma	0.000524	0.000701	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000522	0.000699	CcSEcCtD
Brinzolamide—Discomfort—Prednisone—systemic scleroderma	0.000519	0.000695	CcSEcCtD
Brinzolamide—Mental disorder—Methotrexate—systemic scleroderma	0.000519	0.000695	CcSEcCtD
Brinzolamide—Erythema—Methotrexate—systemic scleroderma	0.000516	0.000691	CcSEcCtD
Brinzolamide—Malnutrition—Methotrexate—systemic scleroderma	0.000516	0.000691	CcSEcCtD
Brinzolamide—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000509	0.000681	CcSEcCtD
Brinzolamide—Dysgeusia—Methotrexate—systemic scleroderma	0.000505	0.000676	CcSEcCtD
Brinzolamide—Nausea—Lisinopril—systemic scleroderma	0.000504	0.000675	CcSEcCtD
Brinzolamide—Infection—Prednisone—systemic scleroderma	0.000501	0.00067	CcSEcCtD
Brinzolamide—Back pain—Methotrexate—systemic scleroderma	0.000499	0.000668	CcSEcCtD
Brinzolamide—Nervous system disorder—Prednisone—systemic scleroderma	0.000494	0.000662	CcSEcCtD
Brinzolamide—Tachycardia—Prednisone—systemic scleroderma	0.000492	0.000658	CcSEcCtD
Brinzolamide—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000491	0.000658	CcSEcCtD
Brinzolamide—Skin disorder—Prednisone—systemic scleroderma	0.000489	0.000655	CcSEcCtD
Brinzolamide—Vision blurred—Methotrexate—systemic scleroderma	0.000486	0.000651	CcSEcCtD
Brinzolamide—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000479	0.000641	CcSEcCtD
Brinzolamide—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000473	0.000633	CcSEcCtD
Brinzolamide—Rash—Mycophenolate mofetil—systemic scleroderma	0.000469	0.000628	CcSEcCtD
Brinzolamide—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000468	0.000627	CcSEcCtD
Brinzolamide—Headache—Mycophenolate mofetil—systemic scleroderma	0.000466	0.000623	CcSEcCtD
Brinzolamide—Malaise—Methotrexate—systemic scleroderma	0.000465	0.000623	CcSEcCtD
Brinzolamide—Vertigo—Methotrexate—systemic scleroderma	0.000464	0.000621	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000459	0.000615	CcSEcCtD
Brinzolamide—Insomnia—Prednisone—systemic scleroderma	0.000456	0.00061	CcSEcCtD
Brinzolamide—Paraesthesia—Prednisone—systemic scleroderma	0.000452	0.000606	CcSEcCtD
Brinzolamide—Cough—Methotrexate—systemic scleroderma	0.00045	0.000603	CcSEcCtD
Brinzolamide—Dyspepsia—Prednisone—systemic scleroderma	0.000443	0.000594	CcSEcCtD
Brinzolamide—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000441	0.000591	CcSEcCtD
Brinzolamide—Myalgia—Methotrexate—systemic scleroderma	0.000439	0.000588	CcSEcCtD
Brinzolamide—Arthralgia—Methotrexate—systemic scleroderma	0.000439	0.000588	CcSEcCtD
Brinzolamide—Chest pain—Methotrexate—systemic scleroderma	0.000439	0.000588	CcSEcCtD
Brinzolamide—Decreased appetite—Prednisone—systemic scleroderma	0.000438	0.000586	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000436	0.000584	CcSEcCtD
Brinzolamide—Fatigue—Prednisone—systemic scleroderma	0.000434	0.000582	CcSEcCtD
Brinzolamide—Discomfort—Methotrexate—systemic scleroderma	0.000434	0.000581	CcSEcCtD
Brinzolamide—Infection—Methotrexate—systemic scleroderma	0.000418	0.00056	CcSEcCtD
Brinzolamide—Feeling abnormal—Prednisone—systemic scleroderma	0.000415	0.000556	CcSEcCtD
Brinzolamide—Nervous system disorder—Methotrexate—systemic scleroderma	0.000413	0.000553	CcSEcCtD
Brinzolamide—Skin disorder—Methotrexate—systemic scleroderma	0.000409	0.000548	CcSEcCtD
Brinzolamide—Urticaria—Prednisone—systemic scleroderma	0.0004	0.000536	CcSEcCtD
Brinzolamide—Hypotension—Methotrexate—systemic scleroderma	0.000393	0.000527	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000384	0.000514	CcSEcCtD
Brinzolamide—Insomnia—Methotrexate—systemic scleroderma	0.000381	0.00051	CcSEcCtD
Brinzolamide—Paraesthesia—Methotrexate—systemic scleroderma	0.000378	0.000506	CcSEcCtD
Brinzolamide—Dyspnoea—Methotrexate—systemic scleroderma	0.000375	0.000503	CcSEcCtD
Brinzolamide—Somnolence—Methotrexate—systemic scleroderma	0.000374	0.000501	CcSEcCtD
Brinzolamide—Hypersensitivity—Prednisone—systemic scleroderma	0.000371	0.000497	CcSEcCtD
Brinzolamide—Dyspepsia—Methotrexate—systemic scleroderma	0.000371	0.000496	CcSEcCtD
Brinzolamide—Decreased appetite—Methotrexate—systemic scleroderma	0.000366	0.00049	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000364	0.000487	CcSEcCtD
Brinzolamide—Fatigue—Methotrexate—systemic scleroderma	0.000363	0.000486	CcSEcCtD
Brinzolamide—Asthenia—Prednisone—systemic scleroderma	0.000361	0.000484	CcSEcCtD
Brinzolamide—Pain—Methotrexate—systemic scleroderma	0.00036	0.000482	CcSEcCtD
Brinzolamide—Pruritus—Prednisone—systemic scleroderma	0.000356	0.000477	CcSEcCtD
Brinzolamide—Feeling abnormal—Methotrexate—systemic scleroderma	0.000347	0.000465	CcSEcCtD
Brinzolamide—Diarrhoea—Prednisone—systemic scleroderma	0.000345	0.000462	CcSEcCtD
Brinzolamide—Urticaria—Methotrexate—systemic scleroderma	0.000334	0.000448	CcSEcCtD
Brinzolamide—Dizziness—Prednisone—systemic scleroderma	0.000333	0.000446	CcSEcCtD
Brinzolamide—Vomiting—Prednisone—systemic scleroderma	0.00032	0.000429	CcSEcCtD
Brinzolamide—Rash—Prednisone—systemic scleroderma	0.000318	0.000425	CcSEcCtD
Brinzolamide—Dermatitis—Prednisone—systemic scleroderma	0.000317	0.000425	CcSEcCtD
Brinzolamide—Headache—Prednisone—systemic scleroderma	0.000316	0.000423	CcSEcCtD
Brinzolamide—Hypersensitivity—Methotrexate—systemic scleroderma	0.00031	0.000415	CcSEcCtD
Brinzolamide—Asthenia—Methotrexate—systemic scleroderma	0.000302	0.000405	CcSEcCtD
Brinzolamide—Nausea—Prednisone—systemic scleroderma	0.000299	0.000401	CcSEcCtD
Brinzolamide—Pruritus—Methotrexate—systemic scleroderma	0.000298	0.000399	CcSEcCtD
Brinzolamide—Diarrhoea—Methotrexate—systemic scleroderma	0.000288	0.000386	CcSEcCtD
Brinzolamide—Dizziness—Methotrexate—systemic scleroderma	0.000278	0.000373	CcSEcCtD
Brinzolamide—Vomiting—Methotrexate—systemic scleroderma	0.000268	0.000358	CcSEcCtD
Brinzolamide—Rash—Methotrexate—systemic scleroderma	0.000265	0.000355	CcSEcCtD
Brinzolamide—Dermatitis—Methotrexate—systemic scleroderma	0.000265	0.000355	CcSEcCtD
Brinzolamide—Headache—Methotrexate—systemic scleroderma	0.000264	0.000353	CcSEcCtD
Brinzolamide—Nausea—Methotrexate—systemic scleroderma	0.00025	0.000335	CcSEcCtD
